Contents
Current Cancer Drug Targets, Volume 12 - Number 4
Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
, 12(4): 303 - 315L. Bagnasco, D. Piras, S. Parodi, I. Bauer, G. Zoppoli, F. Patrone and A. Ballestrero
DOI: 10.2174/156800912800190929
Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
, 12(4): 316 - 328A. Ballestrero, A. Garuti, G. Cirmena, I. Rocco, C. Palermo, A. Nencioni, S. Scabini, G. Zoppoli, S. Parodi and F. Patrone
DOI: 10.2174/156800912800190956
Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer
, 12(4): 329 - 338D. Soncini, I. Caffa, F. Patrone, A. Ballestrero and A. Nencioni
DOI: 10.2174/156800912800190938
A Multi-Scale Approach to Colorectal Cancer: From a Biochemical- Interaction Signaling-Network Level, to Multi-Cellular Dynamics of Malignant Transformation. Interplay with Mutations and Onco-Protein Inhibitor Drugs
, 12(4): 339 - 355L. Tortolina, N. Castagnino, C. De Ambrosi, E. Moran, F. Patrone, A. Ballestrero and S. Parodi
DOI: 10.2174/156800912800190910
DNA Damage Response Pathways and Cell Cycle Checkpoints in Colorectal Cancer: Current Concepts and Future Perspectives for Targeted Treatment
, 12(4): 356 - 371S. Solier, Y. -W. Zhang, A. Ballestrero, Y. Pommier and G. Zoppoli
DOI: 10.2174/156800912800190901
Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
, 12(4): 402 - 438J. J.G. Marin, O. Briz, M. J. Monte, A. G. Blazquez and R. I.R. Macias
DOI: 10.2174/156800912800190875
An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
, 12(4): 439 - 452Nicola Tinari, Michele De Tursi, Antonino Grassadonia, Marinella Zilli, Liborio Stuppia, Stefano Iacobelli and Clara Natoli
DOI: 10.2174/156800912800190884
Webmaster Contact: info@benthamscience.net